Vicks Childrens Liquid
NDC Package 37000-712-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vicks Childrens (phenylephrine hydrochloride and diphenhydramine hydrochloride) liquids is •take only as directed•use dose cup provided •do not exceed 4 doses per 24 hrs adults & children 12 yrs & over 30 mL every 4 hrs children 6 to under 12 yrs 15 mL every 4 hrs children 4 to under 6 yrs do not use unless directed by a doctor children under 4 yrs do not use. This formulation utilizes a liquid delivery system. Marketed by The Procter & Gamble Manufacturing Company, this product is identified by NDC 37000-712 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
37000-712-06
Package Description
177 mL in 1 BOTTLE, PLASTIC
Product Code
37000-712
11-Digit Billing Format
37000071206
RxNorm Crosswalk
  • RxCUI: 2166129 - diphenhydrAMINE HCl 12.5 MG / phenylephrine HCl 5 MG in 15 mL Oral Solution
  • RxCUI: 2166129 - diphenhydramine hydrochloride 0.833 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution
  • RxCUI: 2166129 - diphenhydramine hydrochloride 12.5 MG / phenylephrine hydrochloride 5 MG per 15 ML Oral Solution

Clinical Specifications

Proprietary Name
Vicks Childrens Cough Congestion Night
Non-Proprietary Name
Phenylephrine Hydrochloride And Diphenhydramine Hydrochloride
Substance Name
Diphenhydramine Hydrochloride; Phenylephrine Hydrochloride
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
•take only as directed•use dose cup provided •do not exceed 4 doses per 24 hrs adults & children 12 yrs & over 30 mL every 4 hrs children 6 to under 12 yrs 15 mL every 4 hrs children 4 to under 6 yrs do not use unless directed by a doctor children under 4 yrs do not use

Regulatory & Marketing

Labeler Name
The Procter & Gamble Manufacturing Company
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-22-2019
End Marketing Date
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 37000-712-06 identifies a specific commercial package of 177 ml in 1 bottle, plastic of Vicks Childrens Cough Congestion Night, a human over the counter drug labeled by The Procter & Gamble Manufacturing Company. This liquid is formulated for oral use and contains diphenhydramine hydrochloride; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Procter & Gamble Manufacturing Company on April 22, 2019.

How is this The Procter & Gamble Manufacturing Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 37000071206. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
37000-712-06
11-Digit CMS (5-4-2)
37000-0712-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.